Barry focuses his practice on complex patent litigation. He is an experienced first-chair trial attorney with extensive federal jury and bench trial experience, having tried numerous intellectual property cases to verdict. Although Barry has represented clients at all levels of litigation in various fields of technology, including computer software, medical devices, office furniture, the Internet, insurance, manufacturing, LEDs and telecommunications, he focuses on Hatch-Waxman and consumer electronics litigation.
In addition to handling complex jury and bench trials nationwide, Barry has participated in all aspects of alternative dispute resolution, including arbitrations and mediations. In this regard, he has also developed innovative approaches and strategies to resolve significant disputes to avoid costly litigation.
Barry has led trial teams in more than 75 cases, many settling on favorable terms prior to trial. Barry has extensive experience litigating highly specialized Hatch-Waxman statutory patent infringement actions involving prescription pharmaceutical drugs, including EMEND®, COMBIGAN®, DETROL LA®, ALOXI®, NIASPAN®, SIMCOR®, INTUNIV®, LYSTEDA®, ACULAR LS®, VALCYTE®, PRISTIQ®, TRILIPIX®, and ZEMPLAR®.
A member of the American Intellectual Property Lawyers Association and the American Bar Association, Barry graduated from the University of Miami with a Bachelor of Science in chemistry and earned his law degree from Washington College of Law of the American University.